VR-CARDIO introduces a novel, non-invasive method for generating electro-anatomical heart maps using ECG data alone, eliminating the need for CT or MRI imaging. The software reconstructs cardiac activation in 3D, providing clinicians with fast, precise insights into arrhythmia mechanisms—without the risks or cost of invasive procedures.
Its hardware-agnostic design allows seamless integration into existing hospital ECG infrastructure, expanding access and reducing deployment complexity. The system uses a predefined anatomical atlas, avoiding external imaging dependencies. It includes validated signal analysis, machine learning models, and intuitive 3D visualisation interfaces.
During the project, Spika Tech secured European patent protection for VR-CARDIO (EP23382800), achieved key certifications (ISO 13485, ISO 27001), and is close to obtaining CE marking under MDR 2017/745. Demonstration activities confirmed interoperability, clinical utility, and regulatory readiness.
To support market uptake, a modular SaaS pricing strategy was defined, targeting cardiology and emergency care settings. The commercial rollout will start in Spain, followed by European and US expansion.
Next steps include completing CE certification, expanding clinical validation, and initiating international regulatory pathways (FDA, JFDA). The project demonstrates how advanced signal processing, AI, and immersive technologies can converge to transform cardiac diagnostics.